Cogent Biosciences, Inc.
COGT
$37.93
$0.621.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.97% | 5.02% | -26.64% | -10.07% | -2.14% |
| Total Depreciation and Amortization | 18.53% | 1.23% | -0.52% | -0.86% | 1.67% |
| Total Amortization of Deferred Charges | 2.16% | 16.81% | -20.67% | 376.19% | -- |
| Total Other Non-Cash Items | 1.78% | -27.49% | 109.60% | 5.08% | 9.71% |
| Change in Net Operating Assets | 119.57% | -5,271.97% | -97.23% | -39.25% | 266.14% |
| Cash from Operations | 11.06% | -9.83% | -23.05% | -17.87% | 18.00% |
| Capital Expenditure | 17.59% | 44.64% | -1,147.69% | 50.38% | 76.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 140.69% | 88.82% | -107.74% | -1,814.20% | -87.07% |
| Cash from Investing | 139.17% | 88.70% | -108.18% | -1,840.13% | -87.16% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.71% | -89.38% | 113.29% | 32,793.90% | -97.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -75.56% | -424.92% | -- |
| Cash from Financing | -94.38% | -91.08% | 170.82% | 360.26% | 89.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.21% | -137.90% | 9,606.11% | -223.20% | -94.27% |